Carboplatin (JM8), etoposide (VP16) and thoracic Irradiation for small cell lung cancer (S.C.L.C.): An evaluation of lung toxicity
- 1 May 1988
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 12 (1) , 31-37
- https://doi.org/10.1016/0167-8140(88)90190-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The influence of time sequence of cisplatin administration and continuous low dose rate irradiation (CLDRI) on their combined effects on a murine squamous cell carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Influence of cis-diamminedichloroplatinum (II) on mouse duodenal crypt stem cell survival after multifraction X ray treatmentInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Concurrent cis-diamminedichloroplatinum(II) and radiation treatment for melanoma metastases: A pilot studyRadiotherapy and Oncology, 1985
- The radiomimetic properties of a platinum drugThe British Journal of Radiology, 1985
- Lung destruction aftercis-platinum radiosensitisationThe British Journal of Radiology, 1983
- Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum IICancer Chemotherapy and Pharmacology, 1982
- Enhanced radiation reaction following combination chemotherapy for small cell carcinoma of the lung, possibly secondary to VP16-213International Journal of Radiation Oncology*Biology*Physics, 1982
- The effect of cis-platinum on the repair of radiation damage in plateau phase CHINESE hamster (V-79) cellsInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Response of the murine gastrointestinal epithelium to cis-dichlorodiammineplatinum II: Radiation combinationsInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancerCancer, 1976